deltatrials
Completed PHASE1 INTERVENTIONAL 10-arm NCT04099303

Phase I Clinical Trial of Diphtheria, Tetanus and Acellular Pertussis (Three Components) Combined Vaccine, Adsorbed . (PCTDTcP)

A Randomized,Blind, Positive-controlled Phase I Clinical Trial to Preliminary Evaluate the Safety of DTcP Vaccine in Healthy Children Aged Between 2 Months and 6 Years

Sponsor: CanSino Biologics Inc.

Conditions Diphtheria Pertussis Tetanus
Interventions Diphtheria and Tetanus Combined Vaccine, Adsorbed Diphtheria,Tetanus and Acellular Pertussis (Three Components) Combined Vaccine, Adsorbed Diphtheria,tetanus,pertussis(acellular,component),poliomyelitis(inactivated) vaccine(absorbed) and Haemophilus influenzae type b conjugate vaccine Diphtheria-tetanus-acellular pertussis vaccine
Updated 10 times since 2019 Last updated: Oct 28, 2022 Started: Apr 28, 2020 Primary completion: Oct 27, 2021 Completion: Nov 25, 2021
This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.

A PHASE1 clinical study on Diphtheria and Pertussis, this trial is completed. The trial is conducted by CanSino Biologics Inc. and has accumulated 10 data snapshots since 2020. Longitudinal tracking of this trial contributes to a broader understanding of treatment development timelines.

Status Flow

~Oct 2019 – ~Feb 2020 · 4 months · monthly snapshotNot Yet Recruiting~Feb 2020 – ~May 2020 · 3 months · monthly snapshotNot Yet Recruiting~May 2020 – ~Sep 2020 · 4 months · monthly snapshotRecruiting~Sep 2020 – ~Oct 2020 · 30 days · monthly snapshotActive Not Recruiting~Oct 2020 – ~Jan 2021 · 3 months · monthly snapshotActive Not Recruiting~Jan 2021 – ~Apr 2021 · 3 months · monthly snapshotActive Not Recruiting~Apr 2021 – ~Nov 2022 · 19 months · monthly snapshotActive Not Recruiting~Nov 2022 – ~Jul 2024 · 20 months · monthly snapshotCompleted~Jul 2024 – ~Sep 2024 · 2 months · monthly snapshotCompleted~Sep 2024 – present · 23 months · monthly snapshotCompleted

Change History

10 versions recorded

  1. Sep 2024 — Present [monthly]

    Completed PHASE1

  2. Jul 2024 — Sep 2024 [monthly]

    Completed PHASE1

  3. Nov 2022 — Jul 2024 [monthly]

    Completed PHASE1

    Status: Active Not Recruiting → Completed

  4. Apr 2021 — Nov 2022 [monthly]

    Active Not Recruiting PHASE1

  5. Jan 2021 — Apr 2021 [monthly]

    Active Not Recruiting PHASE1

▶ Show 5 earlier versions

  1. Oct 2020 — Jan 2021 [monthly]

    Active Not Recruiting PHASE1

  2. Sep 2020 — Oct 2020 [monthly]

    Active Not Recruiting PHASE1

    Status: Recruiting → Active Not Recruiting

  3. May 2020 — Sep 2020 [monthly]

    Recruiting PHASE1

    Status: Not Yet Recruiting → Recruiting

  4. Feb 2020 — May 2020 [monthly]

    Not Yet Recruiting PHASE1

  5. Oct 2019 — Feb 2020 [monthly]

    Not Yet Recruiting PHASE1

    First recorded

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:
  • CanSino Biologics Inc.
  • Henan Center for Disease Control and Prevention
Data source: CanSino Biologics Inc.

For direct contact, visit the study record on ClinicalTrials.gov .

Study Locations